To our knowledge, there are no data on the relationship between the 45-bp D/I polymorphism in the UCP2 gene, NAFLD, and T2DM in the population of North-West of Iran. The gene discussed is UCP2; the disease is metabolic dysfunction-associated steatotic liver disease.